University of Utah

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Utah sits in the top decile of US sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count).

818 total trials 138 currently recruiting 492 completed early-phase tilt top decile by trial count

University of Utah: 818 sponsored US clinical trials, 138 recruiting.

University of Utah sponsors 818 registered US clinical trials on ClinicalTrials.gov, 138 of them currently recruiting, and 492 completed. 45 of these trials are in Phase 3-4 (later-stage) and 268 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 8 trials.

Top-decile sponsor footprint

University of Utah ranks in the top decile of sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 41/100

492 of 611 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

818 total, page 12 of 17

TERMINATED Phase 2

Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients

NCT01720043

COMPLETED Phase 4

Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage

NCT01721447

COMPLETED NA

Study of the Cardiovascular Vitamin, CardioLife

NCT02088307

COMPLETED NA

Optimizing Postpartum Contraception in Women With Preterm Births

NCT01864629

TERMINATED

Pin Size Influence the Incidence of Knee Pain

NCT02170480

TERMINATED NA

Micro-Electrodes Implanted in a Human Nerve

NCT02034461

TERMINATED Phase 1

Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

NCT01246869

COMPLETED Phase 2

Two Contrasting Interventions for Sleep Management

NCT01804036

COMPLETED Early Phase 1

Continuous Femoral Nerve Block With a Tibial Plateau Fracture

NCT02168959

COMPLETED

Mindfulness Based Chronic Pain Management: A Pilot Study

NCT01886885

COMPLETED

Insole Sensor to Determine Optimal Limb Loading

NCT02170493

COMPLETED NA

Brief Interventions for Short-Term Suicide Risk Reduction in Military Populations

NCT02042131

COMPLETED NA

Weight Loss Intervention in Long-Haul Truck Drivers: A Pilot Study

NCT02348983

COMPLETED Phase 2

Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients

NCT01710254

COMPLETED

Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts

NCT01656993

COMPLETED Phase 2

Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia

NCT01703169

COMPLETED

Surgical Treatment of Adult Trigger Finger

NCT02196233

COMPLETED

Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis

NCT01735578

COMPLETED

Intramedullary Nailing of Tibia Fractures

NCT01797640

COMPLETED Phase 1

Darbe Administration in Newborns Undergoing Cooling for Encephalopathy

NCT01471015

COMPLETED Phase 1

A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma

NCT01672450

COMPLETED Phase 2

Oral N-acetylcysteine for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo

NCT01612221

COMPLETED

Evaluating Patient and Physician Cost Knowledge in the Emergency Department

NCT01883778

COMPLETED Phase 2

Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance

NCT01614210

COMPLETED Phase 1

Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma

NCT01580969

COMPLETED NA

Laparoscopic Versus Open Appendectomy? Let the Patient Decide

NCT01738750

COMPLETED

Method for Improved Intraoperative Blood Loss Estimates

NCT01634828

COMPLETED

Relationship Between Autonomic Central Nervous System Activation and Atrial Fibrillation Using Functional MRI (fMRI)

NCT02524028

COMPLETED

Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplant

NCT01735565

COMPLETED NA

Effects of High Dietary Fiber Supplementation in Diabetic Chronic Kidney Disease

NCT01838330

TERMINATED

Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates

NCT01735552

COMPLETED NA

Coalition for a Healthier Community-Utah Women and Girls - Phase II (UWAG-II)

NCT02470156

COMPLETED

Smart-phone Application to Promote Medication Adherence in Adolescents and Young Adults (AYA) With Cancer

NCT01618344

COMPLETED NA

A Trial of Supplemental CO2 Versus Room Air in Percutaneous Endoscopic Gastrostomy

NCT02619656

COMPLETED Phase 1

Mitochondrial-related Platelet Transcript Expression Levels in Pre-diabetic Subjects Randomized to Metformin or Placebo

NCT02682121

TERMINATED

Hip Strength and Nerve Palsy After the Modified Stoppa Approach to Acetabular Fracture Reduction and Fixation

NCT01763359

COMPLETED Phase 4

Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing

NCT01993667

TERMINATED Phase 1

Sildenafil and Stroke Recovery

NCT02628847

TERMINATED NA

Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria

NCT01550705

COMPLETED

Results of Rotator Cuff Repair

NCT01549912

TERMINATED Phase 4

Dabigatran's Effect on Changes in Atrial Fibrosis in Patients With Atrial Fibrillation

NCT01546883

COMPLETED Phase 2

Clinical Benefits of a Novel Sleep-focused Mind-body Program on Gulf War Illness (GWI) Symptoms

NCT01543997

COMPLETED Early Phase 1

Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy

NCT01539447

COMPLETED

The Effect of Bariatric Surgery on Peripheral Nerve Function and Axonal Regeneration

NCT02218866

COMPLETED

Psychological Distress and Outcomes in Hip Preservation Patients

NCT01550263

COMPLETED

Nutrient Regulation of Amino Acid Transporters in Aging Human Skeletal Muscle

NCT01669590

COMPLETED

Maternal Immunization: Giving Immunity For Tomorrow

NCT01496079

COMPLETED

To Assess Rotation for Femoral Version and Tibial Torsion

NCT01531296

COMPLETED NA

Body Mind Training Project

NCT01564394

COMPLETED NA

Postoperative Rehabilitation Following Trapeziectomy and Ligament Reconstruction Tendon Interposition

NCT01425034

← Previous Page 12 of 17 Next →

Phase Distribution

PhaseTrial count
Phase 1 145
Phase 2 123
Phase 3 18
Phase 4 27

What is open in the University of Utah pipeline

138 recruiting of 818 indexed (17% open); 492 completed (60%).

Phase mix: 45 late (III/IV) vs 268 early (I/II) (early-phase heavy).

Top condition: Low Back Pain (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Utah: open-pipeline peers nationwide

Peers matched on 818 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of UtahUniversity of Texas Southwestern Medical CenterUniversity of ChicagoDana-Farber Cancer InstituteUniversity of California, San DiegoUniversity of HawaiiPenn State UniversityAdventHealthCSL Behring
University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 818 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this University of Utah page

818 registered trials is a research-attention snapshot, not an endorsement of University of Utah or any single study.

  • 138 of University of Utah's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Low Back Pain is the condition University of Utah studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Utah pipeline card: 818 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.